Aligos Therapeutics partners with Xiamen Amoytop for liver disease treatment using oligonucleotide platform

Under the terms of the agreement, Aligos and Amoytop will collaborate on the research and development of oligonucleotide compounds for the treatment of liv...

May 15, 2023 | Monday | News
UCB and Ariceum Therapeutics Partner for Immune-Related Disease and Cancer Treatment Research

UCB's expertise in macrocyclic peptide discovery, using its proprietary mRNA-display platform, ExtremeDiversity™, will aid Ariceum's discovery of t...

May 11, 2023 | Thursday | News
OliX Pharmaceuticals and DynamiCure Partner for RNA-Based ADC Immunotherapy at Korea-US Business Forum

OliX participated in the ‘Korea-US Digital·BioHealth Business Forum’ hosted by the South Korean Ministry of Health and Welfare and Kor...

May 11, 2023 | Thursday | News
Junshi Biosciences and Dr. Reddy's Partner to Develop Toripalimab in 21 Countries.

“We are thrilled to have established a partnership with Dr. Reddy’s while toripalimab’s global commercial network has been steadily expan...

May 08, 2023 | Monday | News
Amphista Therapeutics Achieves First Discovery Milestone in Collaboration with Bristol Myers Squibb

Nicola Thompson, CEO of Amphista, said, "We are absolutely delighted with the progress and success of our collaboration with BMS. Our ability to deliver ou...

May 05, 2023 | Friday | News
Alphyn Biologics Reports Positive Pediatric Results from Phase 2a Atopic Dermatitis Trial

Alphyn Biologics, a clinical-stage dermatology company developing first-in-class multi-target therapeutics, announced positive results today from the pedia...

May 05, 2023 | Friday | News
Galmed Pharmaceuticals forms a Strategic Partnership with OnKai

OnKai, a US-based technology company, combines public healthcare and medical innovation experience with complex process digitalization, design thinking, an...

May 05, 2023 | Friday | News
Hansa Biopharma, Genethon Collaborate on Imlifidase Pre-Treatment for Crigler-Najjar Syndrome Patients with Anti-AAV Antibodies

The collaboration will, in a clinical study, evaluate the safety and efficacy of Hansa's antibody cleaving enzyme imlifidase as a pre-treatment prior ...

April 28, 2023 | Friday | News
Aditum Bio Announces Formation of Vitalli Bio, Focused on Immunological Disorders

Aditum Bio, the biotech investment firm cofounded in 2019 by former Novartis CEO Joe Jimenez and former President of the Novartis Institutes for BioMedical...

April 28, 2023 | Friday | News
MGI and South Australian Genomics Centre Introduce DNBSEQ-T7* to Supercharge Genomics Research in Australia

Located in the prestigious SAHMRI building in Adelaide, SAGC is a nationally accredited genomics facility that supports research nationally and internation...

April 27, 2023 | Thursday | News
AmerisourceBergen Launches Cell and Gene Therapy Integration Hub

-AmerisourceBergen, a global healthcare company, today announced the launch of its Cell and Gene Therapy (CGT) Integration Hub, a system that can be integr...

April 26, 2023 | Wednesday | News
Agilent and Theragen Bio collaborate to boost cancer genomic profiling through bioinformatic solutions in South Korea.

Agilent Technologies Inc. (NYSE: A) announced the recent signing of a Memorandum of Understanding (MOU) with Theragen Bio in South Korea to boos...

April 26, 2023 | Wednesday | News
Merck introduces Ultimus® Film for enhanced strength and leak resistance in single-use assemblies.

Cutting-edge technology now available in Mobius® 3D process containers Provides 10 times greater abrasion resistance compared to other single-use bi...

April 26, 2023 | Wednesday | News
Trust Your Gut: Balancing the Microbiome for Better Health

A balanced microbiome plays an important role in maintaining human health by promoting protective immune responses and limiting excessive inflammation. But...

April 25, 2023 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close